Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy (Q33376181)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy |
scientific article |
Statements
1 reference
Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy (English)
1 reference
Ruben Niesvizky
1 reference
Tara Naib
1 reference
Paul J Christos
1 reference
David Jayabalan
1 reference
Jessica R Furst
1 reference
Jessica Jalbrzikowski
1 reference
Faiza Zafar
1 reference
Tomer Mark
1 reference
Richard Lent
1 reference
Roger N Pearse
1 reference
Scott Ely
1 reference
John P Leonard
1 reference
Madhu Mazumdar
1 reference
Selina Chen-Kiang
1 reference
Morton Coleman
1 reference
1 September 2007
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference